Remix Therapeutics Email Formats
Biotechnology Research • 
Watertown, Massachusetts, United States • 51-100 Employees
Remix Therapeutics Email Formats
Remix Therapeutics uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@remixtx.com), used 61.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@remixtx.com | 61.7% |
{first initial}{last name} | jdoe@remixtx.com | 34% |
{second initial}{last name} | odoe@remixtx.com | 2.1% |
{last name}{last name} | doedoe@remixtx.com | 2.1% |
Key Contacts at Remix Therapeutics
Alexander Ivliev
Director, Bioinformatics & Data Science
Yaguang Si
Senior Director Biology
Sarah Sirin
Director And Head Of Computational Chemistry
Nirodhini Siriwardana
Associate Director, Biomolecular Sciences And Lead Discovery
Jesper Maag
Associate Director, Bioinformatics & Data Science
Andy Snyder
Director
Anant A. Agrawal
Director
Samuel Perry
Senior Director Of Operations
Katie Kirwin Reznicek
Associate Director, Program And Alliance Management
Bryan Dunyak
Director
Company overview
| Headquarters | 100 Forge Rd, Watertown, MA, MA 02472, US |
| Phone number | +17818270901 |
| Website | |
| NAICS | 541714 |
| Founded | 2018 |
| Employees | 51-100 |
| Socials |
About Remix Therapeutics
Remix is working to transform patient's lives through modulation of RNA processing and addressing drug targets in diseases of high unmet medical need. We are a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin. Remix's REMaster™ technology platform leverages cutting-edge data science, biomolecular sciences and chemistry approaches to identify orally administered compounds that modulate gene expression. Remix's innovative therapeutic approach led to the discovery of REM-422, a first-in-class RNA processing modulator in oncology, now being evaluated in Phase 1 clinical studies to treat acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (HR-MDS) and adenoid cystic carcinoma (ACC).
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Remix Therapeutics has 20 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Remix Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Remix Therapeutics Tech Stack
Discover the technologies and tools that power Remix Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Analytics
JavaScript libraries
JavaScript frameworks
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
JavaScript frameworks
SEO
Tag managers
France
Belgium
Palestine, State of
United Kingdom
Australia
IndiaFrequently asked questions
4.8
40,000 users
